References
- Gabizon A., Sulkes A., Peretz T., Druckmann S., Goren D., Amselem S., Barenholz Y. Liposome-associated doxorubicin: preclinical pharmacology and exploratory clinical phase. Liposomes in the therapy of Infectious Diseases and Cancer, UCLA Symposia on Molecular and Cellular Biology, New Series Vol. 89, A. Lopez-Berestein, I.J. Fidler. Alan R. Liss, New York 1989; 391–402
- Treat J., Greenspan A.R., Rahman A. Liposome encapsulated doxorubicin: preliminary results of phase I and phase II trials. Liposomes in the therapy of Infectious Diseases and Cancer, UCLA Symposia on Molecular and Cellular Biology, New Series Vol. 89, A. Lopez-Berestein, I.J. Fidler. Alan R. Liss, New York 1989; 353–365
- Creaven P.J., Brenner D.E., Cowens J.W., Huben R., Karakousis C., Han T., Dadey B., Andrejcio K., Cushman M.K. Initial clinical trial of muramyl tripeptide derivative (MTP-PE) encapsulated in liposomes: an interim report. Liposomes in the therapy of Infectious Diseases and Cancer, UCLA Symposia on Molecular and Cellular Biology, New Series Vol. 89, A. Lopez-Berestein, I.J. Fidler. Alan R. Liss, New York 1989; 297–303
- Creaven P.J., Brenner D.E., Cowens J.W., Han T., Dadey B.M., LeSher D., Hanagan J., Andrejcio K., Cushman M.K. (1989) Phase I study of the macrophage activator CGP 19835A encapsulated in liposomes. Proceedings, Sixth NCI-EORTC Symposium on New Drugs in Cancer therapy, Amsterdam, March, 1989, Abst. #271
- Weinstein J.M. Liposomes in the diagnosis and treatment of cancer. Liposomes: From Biophysics to therapeutics, M.J. Ostro. Marcel Dekker, New York 1987; 277–338